Wpływ suplementacji diety selenem na przebieg autoimmunologicznego zapalenia tarczycy – przegląd badań klinicznych przeprowadzonych w populacji europejskiej
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Caturegli P., De Remigis A., Chuang K., Dembele M., Iwama A., Iwama S.: Hashimoto’s thyroiditis: Celebrating the centennial through the lens of the Johns Hopkins Hospital surgical pathology records. Thyroid, 2013; 23: 142-150CaturegliP.De RemigisA.ChuangK.DembeleM.IwamaA.IwamaS.Hashimoto’s thyroiditis: Celebrating the centennial through the lens of the Johns Hopkins Hospital surgical pathology recordsThyroid20132314215010.1089/thy.2012.0554356996623151083Search in Google Scholar
Hiromatsu Y., Satoh H., Amino N.: Hashimoto’s thyroiditis: History and future outlook. Hormones, 2013; 12: 12-18HiromatsuY.SatohH.AminoN.Hashimoto’s thyroiditis: History and future outlookHormones201312121810.1007/BF0340128223624127Search in Google Scholar
Pearce E.N., Farwell A.P., Braverman L.E.: Thyroiditis. N. Engl. J. Med., 2003; 348: 2646-2655PearceE.N.FarwellA.P.BravermanL.E.ThyroiditisN. Engl. J. Med20033482646265510.1056/NEJMra02119412826640Search in Google Scholar
Bülow Pedersen I., Knudsen N., Carlé A., Schomburg L., Köhrle J., Jørgensen T., Rasmussen L.B., Ovesen L., Laurberg P.: Serum selenium is low in newly diagnosed Graves’ disease: A population-based study. Clin. Endocrinol., 2013; 79: 584-590BülowPedersen I.KnudsenN.CarléA.SchomburgL.KöhrleJ.JørgensenT.RasmussenL.B.OvesenL.LaurbergP.Serum selenium is low in newly diagnosed Graves’ disease: A population-based studyClin. Endocrinol20137958459010.1111/cen.1218523448365Search in Google Scholar
Glattre E., Nygård J.F., Aaseth J.: Selenium and cancer prevention: Observations and complexity. J. Trace Elem. Med. Biol., 2012; 26: 168-169GlattreE.NygårdJ.F.AasethJ.Selenium and cancer prevention: Observations and complexityJ. Trace Elem. Med. Biol20122616816910.1016/j.jtemb.2012.04.02122664335Search in Google Scholar
Rasmussen L.B., Schomburg L., Köhrle J., Pedersen I.B., Hollenbach B., Hög A., Ovesen L., Perrild H., Laurberg P.: Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur. J. Endocrinol., 2011; 164: 585-590RasmussenL.B.SchomburgL.KöhrleJ.PedersenI.B.HollenbachB.HögA.OvesenL.PerrildH.LaurbergP.Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiencyEur. J. Endocrinol201116458559010.1530/EJE-10-102621242171Search in Google Scholar
Wu Q., Rayman M.P., Lv H., Schomburg L., Cui B., Gao C., Chen P., Zhuang G., Zhang Z., Peng X., Li H., Zhao Y., He X., Zeng G., Qin F., Hou P., Shi B.: Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab., 2015; 100: 4037-4047WuQ.RaymanM.P.LvH.SchomburgL.CuiB.GaoC.ChenP.ZhuangG.ZhangZ.PengX.LiH.ZhaoY.HeX.ZengG.QinF.HouP.ShiB.Low population selenium status is associated with increased prevalence of thyroid diseaseJ. Clin. Endocrinol. Metab20151004037404710.1210/jc.2015-222226305620Search in Google Scholar
Aaseth J., Frey H., Glattre E., Norheim G., Ringstad J., Thomassen Y.: Selenium concentrations in the human thyroid gland. Biol. Trace Elem. Res., 1990; 24: 147-152AasethJ.FreyH.GlattreE.NorheimG.RingstadJ.ThomassenY.Selenium concentrations in the human thyroid glandBiol. Trace Elem. Res19902414715210.1007/BF029172021702666Search in Google Scholar
Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., Hesketh J.E.: Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J., 1995; 311: 425-430BermanoG.NicolF.DyerJ.A.SundeR.A.BeckettG.J.ArthurJ.R.HeskethJ.E.Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in ratsBiochem. J199531142543010.1042/bj311042511360177487877Search in Google Scholar
Schomburg L.: Selenium, selenoproteins and the thyroid gland: Interactions in health and disease. Nat. Rev. Endocrinol., 2011; 8: 160-171SchomburgL.Selenium, selenoproteins and the thyroid gland: Interactions in health and diseaseNat. Rev. Endocrinol2011816017110.1038/nrendo.2011.17422009156Search in Google Scholar
Gärtner R., Gasnier B.C., Dietrich J.W., Krebs B., Angstwurm M.W.: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab., 2002; 87: 1687-1691GärtnerR.GasnierB.C.DietrichJ.W.KrebsB.AngstwurmM.W.Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrationsJ. Clin. Endocrinol. Metab2002871687169110.1210/jc.87.4.1687Search in Google Scholar
Gärtner R., Gasnier B.C.: Selenium in the treatment of autoimmune thyroiditis. Biofactors, 2003; 19: 165-170GärtnerR.GasnierB.C.Selenium in the treatment of autoimmune thyroiditisBiofactors20031916517010.1002/biof.552019030914757967Search in Google Scholar
Duntas L.H., Mantzou E., Koutras D.A.: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol., 2003; 148: 389-393DuntasL.H.MantzouE.KoutrasD.A.Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditisEur. J. Endocrinol200314838939310.1530/eje.0.148038912656658Search in Google Scholar
Turker O., Kumanlioglu K., Karapolat I., Dogan I.: Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol., 2006; 190: 151-156TurkerO.KumanliogluK.KarapolatI.DoganI.Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable dosesJ. Endocrinol200619015115610.1677/joe.1.0666116837619Search in Google Scholar
Mazokopakis E.E., Papadakis J.A., Papadomanolaki M.G., Batistakis A.G., Giannakopoulos T.G., Protopapadakis E.E., Ganotakis E.S.: Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid, 2007; 17: 609-612MazokopakisE.E.PapadakisJ.A.PapadomanolakiM.G.BatistakisA.G.GiannakopoulosT.G.ProtopapadakisE.E.GanotakisE.S.Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditisThyroid20071760961210.1089/thy.2007.004017696828Search in Google Scholar
Karanikas G., Schuetz M., Kontur S., Duan H., Kommata S., Schoen R., Antoni A., Kletter K., Dudczak R., Willheim M.: No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 2008; 18: 7-12KaranikasG.SchuetzM.KonturS.DuanH.KommataS.SchoenR.AntoniA.KletterK.DudczakR.WillheimM.No immunological benefit of selenium in consecutive patients with autoimmune thyroiditisThyroid20081871210.1089/thy.2007.012718302514Search in Google Scholar
Balázs C., Fehér J.: The effect of selenium therapy on autoimmune thyroiditis. Clin. Exp. Med. J., 2009; 3: 269-277BalázsC.FehérJ.The effect of selenium therapy on autoimmune thyroiditisClin. Exp. Med. J2009326927710.1556/CEMED.3.2009.28408Search in Google Scholar
Nacamulli D., Mian C., Petricca D., Lazzarotto F., Barollo S., Pozza D., Masiero S., Faggian D., Plebani M., Girelli M.E., Mantero F., Betterle C.: Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol., 2010; 73: 535-539NacamulliD.MianC.PetriccaD.LazzarottoF.BarolloS.PozzaD.MasieroS.FaggianD.PlebaniM.GirelliM.E.ManteroF.BetterleC.Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditisClin. Endocrinol20107353553910.1111/j.1365-2265.2009.03758.x20039895Search in Google Scholar
Krysiak R., Okopien B.: The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 2011; 96: 2206-2215KrysiakR.OkopienB.The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditisJ. Clin. Endocrinol. Metab2011962206221510.1210/jc.2010-298621508145Search in Google Scholar
Anastasilakis A.D., Toulis K.A., Nisianakis P., Goulis D.G., Kampas L., Valeri R.M., Oikonomou D., Tzellos T.G., Delaroudis S.: Selenomethionine treatment in patients with autoimmune thyroiditis: A prospective, quasi-randomised trial. Int. J. Clin. Pract., 2012; 66: 378-383AnastasilakisA.D.ToulisK.A.NisianakisP.GoulisD.G.KampasL.ValeriR.M.OikonomouD.TzellosT.G.DelaroudisS.Selenomethionine treatment in patients with autoimmune thyroiditis: A prospective, quasi-randomised trialInt. J. Clin. Pract20126637838310.1111/j.1742-1241.2011.02879.x22356267Search in Google Scholar
Eskes S.A., Endert E., Fliers E., Birnie E., Hollenbach B., Schomburg L., Köhrle J., Wiersinga W.M.: Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin. Endocrinol., 2014; 80: 444-451EskesS.A.EndertE.FliersE.BirnieE.HollenbachB.SchomburgL.KöhrleJ.WiersingaW.M.Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodiesClin. Endocrinol20148044445110.1111/cen.1228423844613Search in Google Scholar
Pilli T., Cantara S., Schomburg L., Cenci V., Cardinale S., Heid E.C., Kühn E.C., Cevenini G., Sestini F., Fioravanti C., D’Hauw G., Pacini F.: IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: Comparison between two doses of selenomethionine (80 or 160 μg) versus placebo. Eur. Thyroid J., 2015; 4: 226-233PilliT.CantaraS.SchomburgL.CenciV.CardinaleS.HeidE.C.KühnE.C.CeveniniG.SestiniF.FioravantiC.D’HauwG.PaciniF.IFNγ-inducible chemokines decrease upon selenomethionine supplementation in women with euthyroid autoimmune thyroiditis: Comparison between two doses of selenomethionine (80 or 160 μg) versus placeboEur. Thyroid J2015422623310.1159/000439589471642326835425Search in Google Scholar
Esposito D., Rotondi M., Accardo G., Vallone G., Conzo G., Docimo G., Selvaggi F., Cappelli C., Chiovato L., Giugliano D., Pasquali D.: Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: Clinical results of a blinded placebo-controlled randomized prospective trial. J. Endocrinol. Invest., 2017; 40: 83-89EspositoD.RotondiM.AccardoG.ValloneG.ConzoG.DocimoG.SelvaggiF.CappelliC.ChiovatoL.GiuglianoD.PasqualiD.Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: Clinical results of a blinded placebo-controlled randomized prospective trialJ. Endocrinol. Invest201740838910.1007/s40618-016-0535-427572248Search in Google Scholar
Pirola I., Rotondi M., Cristiano A., Maffezzoni F., Pasquali D., Marini F., Coperchini F., Paganelli M., Apostoli P., Chiovato L. i wsp.: Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study. Endocrinol. Diabetes Nutr., 2020; 67: 28-35PirolaI.RotondiM.CristianoA.MaffezzoniF.PasqualiD.MariniF.CoperchiniF.PaganelliM.ApostoliP.ChiovatoL. i wsp.Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI studyEndocrinol. Diabetes Nutr202067283510.1016/j.endinu.2019.03.01831196739Search in Google Scholar
Manevska N., Stojanoski S., Makazlieva T.: Selenium treatment effect in auto-immune hashimoto thyroiditis in macedonian population. J. Endocrinol. Metab., 2019; 9: 22-28ManevskaN.StojanoskiS.MakazlievaT.Selenium treatment effect in auto-immune hashimoto thyroiditis in macedonian populationJ. Endocrinol. Metab20199222810.14740/jem551Search in Google Scholar
Krohn K., Maier J., Paschke R.: Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat. Clin. Pract. Endocrinol. Metab., 2007; 3: 713-720KrohnK.MaierJ.PaschkeR.Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumorsNat. Clin. Pract. Endocrinol. Metab2007371372010.1038/ncpendmet062117893690Search in Google Scholar
Hendriksen M.A., van Raaij J.M., Geleijnse J.M., van den Hooven C.W., Ocké M.C., van der A D.: Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretions. Public Health Nutr., 2014; 17: 1431-1438HendriksenM.A.van RaaijJ.M.GeleijnseJ.M.van denHooven C.W.OckéM.C.van derA D.Monitoring salt and iodine intakes in Dutch adults between 2006 and 2010 using 24 h urinary sodium and iodine excretionsPublic Health Nutr2014171431143810.1017/S136898001300148123739290Search in Google Scholar
Karunasinghe N., Han D.Y., Zhu S., Yu J., Lange K., Duan H., Medhora R., Singh N., Kan J., Alzaher W., Chen B., Ko S., Triggs C.M., Ferguson L.R.: Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: Relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr., 2012; 7: 179-190KarunasingheN.HanD.Y.ZhuS.YuJ.LangeK.DuanH.MedhoraR.SinghN.KanJ.AlzaherW.ChenB.KoS.TriggsC.M.FergusonL.R.Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: Relationship to markers of oxidative stress in men from Auckland, New ZealandGenes Nutr2012717919010.1007/s12263-011-0259-1331674522139612Search in Google Scholar
Jablonska E., Gromadzinska J., Reszka E., Wasowicz W., Sobala W., Szeszenia-Dabrowska N., Boffetta P.: Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur. J. Nutr., 2009; 48: 383-386JablonskaE.GromadzinskaJ.ReszkaE.WasowiczW.SobalaW.Szeszenia-DabrowskaN.BoffettaP.Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humansEur. J. Nutr20094838338610.1007/s00394-009-0023-019415410Search in Google Scholar
de Farias C.R., Cardoso B.R., de Oliveira G.M., de Mello Guazzelli I.C., Catarino R.M., Chammas M.C., Cozzolino S.M., Knobel M.: A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J. Endocrinol. Invest., 2015; 38: 1065-1074de FariasC.R.CardosoB.R.de OliveiraG.M.de Mello GuazzelliI.C.CatarinoR.M.ChammasM.C.CozzolinoS.M.KnobelM.A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypesJ. Endocrinol. Invest2015381065107410.1007/s40618-015-0285-825894865Search in Google Scholar
Curran J.E., Jowett J.B., Elliott K.S., Gao Y., Gluschenko K., Wang J., Abel Azim D.M., Cai G., Mahaney M.C., Comuzzie A.G. i wsp.: Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet., 2005; 37: 1234-1241CurranJ.E.JowettJ.B.ElliottK.S.GaoY.GluschenkoK.WangJ.AbelAzim D.M.CaiG.MahaneyM.C.ComuzzieA.G. i wsp.Genetic variation in selenoprotein S influences inflammatory responseNat. Genet2005371234124110.1038/ng165516227999Search in Google Scholar
Bretz J.D., Arscott P.L., Myc A., Baker J.R.Jr.: Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J. Biol. Chem., 1999; 274: 25433-25438BretzJ.D.ArscottP.L.MycA.BakerJ.R.Jr.Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cellsJ. Biol. Chem1999274254332543810.1074/jbc.274.36.2543310464273Search in Google Scholar
Mezosi E., Wang S.H., Utsugi S., Bajnok L., Bretz J.D., Gauger P.G., Thompson N.W., Baker J.R.Jr.: Interleukin-1β and tumor necrosis factor (TNF)-α sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity. J. Clin. Endocrinol. Metab., 2004; 89: 250-257MezosiE.WangS.H.UtsugiS.BajnokL.BretzJ.D.GaugerP.G.ThompsonN.W.BakerJ.R.Jr.Interleukin-1β and tumor necrosis factor (TNF)-α sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activityJ. Clin. Endocrinol. Metab20048925025710.1210/jc.2003-03069714715858Search in Google Scholar
Wang S.H., Van Antwerp M., Kuick R., Gauger P.G., Doherty G.M., Fan Y.Y., Baker J.R.Jr.: Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology, 2007; 148: 4844-4852WangS.H.VanAntwerp M.KuickR.GaugerP.G.DohertyG.M.FanY.Y.BakerJ.R.Jr.Microarray analysis of cytokine activation of apoptosis pathways in the thyroidEndocrinology20071484844485210.1210/en.2007-012617640998Search in Google Scholar
Antonelli A., Ferrari S.M., Giuggioli D., Ferrannini E., Ferri C., Fallahi P.: Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun. Rev., 2014; 13: 272-280AntonelliA.FerrariS.M.GiuggioliD.FerranniniE.FerriC.FallahiP.Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseasesAutoimmun. Rev20141327228010.1016/j.autrev.2013.10.01024189283Search in Google Scholar
Santos L.R., Durães C., Mendes A., Prazeres H., Alvelos M.I., Moreira C.S., Canedo P., Esteves C., Neves C., Carvalho D., Sobrinho-Simões M., Soares P.: A polymorphism in the promoter region of the selenoprotein Sgene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab., 2014; 99: E719-E723SantosL.R.DurãesC.MendesA.PrazeresH.AlvelosM.I.MoreiraC.S.CanedoP.EstevesC.NevesC.CarvalhoD.Sobrinho-SimõesM.SoaresP.A polymorphism in the promoter region of the selenoprotein Sgene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibilityJ. Clin. Endocrinol. Metab201499E719E72310.1210/jc.2013-353924471570Search in Google Scholar
Wasniewska M., Vigone M.C., Cappa M., Aversa T., Rubino M., De Luca F., Study Group for Thyroid diseases of Italian Society for Pediatric Endocrinology: Acute suppurative thyroiditis in childhood: Relative frequency among thyroid inflammatory diseases. J. Endocrinol. Invest., 2007; 30: 346-347WasniewskaM.VigoneM.C.CappaM.AversaT.RubinoM.De LucaF.Study Group for Thyroid diseases of Italian Society for Pediatric Endocrinology: Acute suppurative thyroiditis in childhood: Relative frequency among thyroid inflammatory diseasesJ. Endocrinol. Invest20073034634710.1007/BF0334630317556874Search in Google Scholar
De Luca F., Santucci S., Corica D., Pitrolo E., Romeo M., Aversa T.: Hashimoto’s thyroiditis in childhood: Presentation modes and evolution over time. Ital. J. Pediatr., 2013; 39: 8De LucaF.SantucciS.CoricaD.PitroloE.RomeoM.AversaT.Hashimoto’s thyroiditis in childhood: Presentation modes and evolution over timeItal. J. Pediatr201339810.1186/1824-7288-39-8356797623363471Search in Google Scholar
Bonfig W., Gärtner R., Schmidt H.: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Sci. World J., 2010; 10: 990-996BonfigW.GärtnerR.SchmidtH.Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditisSci. World J20101099099610.1100/tsw.2010.91576381620526530Search in Google Scholar
Nourbakhsh M., Ahmadpour F., Chahardoli B., Malekpour-Dehkordi Z., Nourbakhsh M., Hosseini-Fard S.R., Doustimotlagh A., Golestani A., Razzaghy-Azar M.: Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidism. J. Trace Elem. Med. Biol., 2016; 34: 10-14NourbakhshM.AhmadpourF.ChahardoliB.Malekpour-DehkordiZ.NourbakhshM.Hosseini-FardS.R.DoustimotlaghA.GolestaniA.Razzaghy-AzarM.Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto’s thyroiditis and hypothyroidismJ. Trace Elem. Med. Biol201634101410.1016/j.jtemb.2015.10.00326854239Search in Google Scholar
Stagnaro-Green A.: Approach to the patient with postpartum thyroiditis. J. Clin. Endocrinol. Metab., 2012; 97: 334-342Stagnaro-GreenA.Approach to the patient with postpartum thyroiditisJ. Clin. Endocrinol. Metab20129733434210.1210/CAEM3.9781936704866.ch4Search in Google Scholar
Korevaar T.I., Schalekamp-Timmermans S., de Rijke Y.B., Visser W.E., Visser W., de Muinck Keizer-Schrama S.M., Hofman A., Ross H.A., Hooijkaas H., Tiemeier H., Bongers-Schokking J.J., Jaddoe V.W., Visser T.J., Steegers E.A., Medici M., Peeters R.P.: Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: The generation R study. J. Clin. Endocrinol. Metab., 2013; 98: 4382-4390KorevaarT.I.Schalekamp-TimmermansS.de RijkeY.B.VisserW.E.VisserW.de MuinckKeizer-Schrama S.M.HofmanA.RossH.A.HooijkaasH.TiemeierH.Bongers-SchokkingJ.J.JaddoeV.W.VisserT.J.SteegersE.A.MediciM.PeetersR.P.Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: The generation R studyJ. Clin. Endocrinol. Metab2013984382439010.1210/jc.2013-285524037884Search in Google Scholar
Thangaratinam S., Tan A., Knox E., Kilby M.D., Franklyn J., Coomarasamy A.: Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ, 2011; 342: d2616ThangaratinamS.TanA.KnoxE.KilbyM.D.FranklynJ.CoomarasamyA.Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidenceBMJ2011342d261610.1097/01.aoa.0000414067.82440.e6Search in Google Scholar
Negro R., Greco G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H.: The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab., 2007; 92: 1263-1268NegroR.GrecoG.MangieriT.PezzarossaA.DazziD.HassanH.The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodiesJ. Clin. Endocrinol. Metab2007921263126810.1210/jc.2006-182117284630Search in Google Scholar
Mao J., Pop V.J., Bath S.C., Vader H.L., Redman C.W., Rayman M.P.: Effect of low‑dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild‑to‑moderate iodine deficiency. Eur. J. Nutr., 2016; 55: 55-61MaoJ.PopV.J.BathS.C.VaderH.L.RedmanC.W.RaymanM.P.Effect of low‑dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild‑to‑moderate iodine deficiencyEur. J. Nutr201655556110.1007/s00394-014-0822-9473778625524327Search in Google Scholar
Karanikas G., Schuetz M., Wahl K., Paul M., Kontur S., Pietschmann P., Kletter K., Dudczak R., Willheim M.: Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin. Endocrinol., 2005; 63: 191-196KaranikasG.SchuetzM.WahlK.PaulM.KonturS.PietschmannP.KletterK.DudczakR.WillheimM.Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditisClin. Endocrinol20056319119610.1111/j.1365-2265.2005.02324.x16060913Search in Google Scholar
Pállinger E., Csaba G.: A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells. Immunology, 2008; 123: 584-589PállingerE.CsabaG.A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cellsImmunology200812358458910.1111/j.1365-2567.2007.02731.x243331618005034Search in Google Scholar
Rotondi M., Chiovato L., Romagnani S., Serio M., Romagnani P.: Role of chemokines in endocrine autoimmune diseases. Endocr. Rev., 2007; 28: 492-520RotondiM.ChiovatoL.RomagnaniS.SerioM.RomagnaniP.Role of chemokines in endocrine autoimmune diseasesEndocr. Rev20072849252010.1210/er.2006-004417475924Search in Google Scholar
Antonelli A., Ferrari S.M., Frascerra S., Di Domenicantonio A., Nicolini A., Ferrari P., Ferrannini E., Fallahi P.: Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab., 2011; 96: 1859-1863AntonelliA.FerrariS.M.FrascerraS.DiDomenicantonio A.NicoliniA.FerrariP.FerranniniE.FallahiP.Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditisJ. Clin. Endocrinol. Metab2011961859186310.1210/jc.2010-290521470996Search in Google Scholar
Antonelli A., Ferrari S.M., Frascerra S., Galetta F., Franzoni F., Corrado A., Miccoli M., Benvenga S., Paolicchi A., Ferrannini E., Fallahi P.: Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine, 2011; 55: 288-293AntonelliA.FerrariS.M.FrascerraS.GalettaF.FranzoniF.CorradoA.MiccoliM.BenvengaS.PaolicchiA.FerranniniE.FallahiP.Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10Cytokine20115528829310.1016/j.cyto.2011.04.02221601475Search in Google Scholar
Antonelli A., Ferri C., Ferrari S.M., Frascerra S., Ruffilli I., Caponi L., Ulisse S., Miccoli M., Miccoli P., Fallahi P.: High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10. J. Interferon Cytokine Res., 2012; 32: 74-80AntonelliA.FerriC.FerrariS.M.FrascerraS.RuffilliI.CaponiL.UlisseS.MiccoliM.MiccoliP.FallahiP.High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10J. Interferon Cytokine Res201232748010.1089/jir.2011.005122168752Search in Google Scholar
Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Buonamano A., Ferrannini E., Serio M.: High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J. Clin. Endocrinol. Metab., 2004; 89: 5496-5499AntonelliA.RotondiM.FallahiP.RomagnaniP.FerrariS.M.BuonamanoA.FerranniniE.SerioM.High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidismJ. Clin. Endocrinol. Metab2004895496549910.1210/jc.2004-097715531503Search in Google Scholar
Nanba T., Watanabe M., Inoue N., Iwatani Y.: Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid, 2009; 19: 495-501NanbaT.WatanabeM.InoueN.IwataniY.Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ diseaseThyroid20091949550110.1089/thy.2008.042319415997Search in Google Scholar
Phenekos C., Vryonidou A., Gritzapis A.D., Baxevanis C.N., Goula M., Papamichail M.: Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation, 2004; 11: 209-213PhenekosC.VryonidouA.GritzapisA.D.BaxevanisC.N.GoulaM.PapamichailM.Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2)Neuroimmunomodulation20041120921310.1159/00007843815249726Search in Google Scholar
Konca Degertekin C., Aktas Yilmaz B., Balos Toruner F., Kalkanci A., Turhan Iyidir O., Fidan I., Yesilyurt E., Cakır N., Kustimur S., Arslan M.: Circulating Th17 cytokine levels are altered in Hashimoto’s thyroiditis. Cytokine, 2016; 80: 13-17KoncaDegertekin C.AktasYilmaz B.BalosToruner F.KalkanciA.TurhanIyidir O.FidanI.YesilyurtE.CakırN.KustimurS.ArslanM.Circulating Th17 cytokine levels are altered in Hashimoto’s thyroiditisCytokine201680131710.1016/j.cyto.2016.02.01126928603Search in Google Scholar
Li D., Cai W., Gu R., Zhang Y., Zhang H., Tang K., Xu P., Katirai F., Shi W., Wang L., Huang T., Huang B.: Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin. Immunol., 2013; 149: 411-420LiD.CaiW.GuR.ZhangY.ZhangH.TangK.XuP.KatiraiF.ShiW.WangL.HuangT.HuangB.Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patientsClin. Immunol201314941142010.1016/j.clim.2013.10.00124211715Search in Google Scholar
Xue H., Yu X., Ma L., Song S., Li Y., Zhang L., Yang T., Liu H.: The possible role of CD4+CD25highFoxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine, 2015; 50: 665-673XueH.YuX.MaL.SongS.LiY.ZhangL.YangT.LiuH.The possible role of CD4+CD25highFoxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditisEndocrine20155066567310.1007/s12020-015-0569-y25771887Search in Google Scholar
Wichman J., Winther K.H., Bonnema S.J., Hegedüs L.: Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis. Thyroid, 2016; 26: 1681-1692WichmanJ.WintherK.H.BonnemaS.J.HegedüsL.Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysisThyroid2016261681169210.1089/thy.2016.025627702392Search in Google Scholar
Winther K.H., Wichman J.E.M., Bonnema S.J., Hegedüs L.: Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine, 2017; 55: 376-385WintherK.H.WichmanJ.E.M.BonnemaS.J.HegedüsL.Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysisEndocrine20175537638510.1007/s12020-016-1098-z527287727683225Search in Google Scholar